Capital Impact Advisors, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Capital Impact Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.06 - $1.67 $199,048 - $313,595	-187,782 Reduced 36.36%	328,667 $381,000
Q4 2023 Feb 14, 2024	BUY	$1.26 - $1.79 $421,294 - $598,506	334,361 Added 183.63%	516,449 $872,000
Q1 2023 May 23, 2023	BUY	$1.2 - $2.19 $161,457 - $294,660	134,548 Added 283.02%	182,088 $242,000
Q4 2022 Feb 14, 2023	SELL	$1.63 - $3.52 $12,094 - $26,118	-7,420 Reduced 13.5%	47,540 $80,000
Q3 2022 Nov 21, 2022	BUY	$0.73 - $3.74 $40,120 - $205,550	54,960 New	54,960 $118,000

345

925M

1.04M

2.23M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.5B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Impact Advisors, LLC with notifications on news.